Top Markets
#1 Palladium Network Palladium Network +27.94%
#2 MarsCoin MarsCoin +25.78%
#3 Hive Hive +25.60%
#4 Siren Siren +24.48%
#5 BankrCoin BankrCoin +20.74%
#6 Ankr Network Ankr Network +17.93%
#7 StonkBroker StonkBroker +16.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
#9 Status Status +11.03%
#10 Provenance Blockchain Provenance Blockchain +8.81%
Coin of the day
Palladium Network Palladium Network
Settings
Language
ENGLISH
Currency
USD
Theme
Merrimack Pharmaceuticals, Inc. Merrimack Pharmaceuticals, Inc.

Merrimack Pharmaceuticals, Inc.

MACK
Rank in Stocks #18348
Founded in 1993, Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company... Founded in 1993, Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts.
Share Price
$15.13
Last synced: 2024-05-28
Market Cap
$202.89M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Merrimack Pharmaceuticals, Inc. (MACK)

Category

Healthcare
Revenue for Merrimack Pharmaceuticals, Inc. (MACK)
Revenue in Mar 2024 TTM: 0.00
According to Merrimack Pharmaceuticals, Inc. latest financial reports the company's current revenue (TTM) is 0.00. In 2022 the company made a revenue of 0.00 equal to the revenue in the year 2021 that was 0.00. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Merrimack Pharmaceuticals, Inc. from 2009 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 -100.00%
2016 $144.27M 61.64%
2015 $89.26M -13.14%
2014 $102.76M 115.03%
2013 $47.79M -2.32%
2012 $48.92M 42.98%
2011 $34.22M 68.51%
2010 $20.31M 845.30%
2009 $2.15M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH